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Knockout of the Vesicular Monoamine
Transporter 2 Gene Results in Neonatal Death
and Supersensitivity to Cocaine and Amphetamine
The actions of monoamines are mediated almost ex-
clusively by G protein±coupled receptors, but the intra-
and extracellular concentrations of monoamines are
primarily controlled by two types of transporters. Na1/
Cl2-dependent plasma membrane transporters play an
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active role in terminating neurotransmission by remov-Department of Cell Biology
ing transmitters from the extracellular space, while ve-Duke University Medical Center
sicular transporters prepare synaptic vesicles for stimu-Durham, North Carolina 27710
lated release by transporting monoamines from the
cytoplasm into the vesicles. Classical pharmacology
and molecular biology have identified two subtypes ofSummary
the vesicular monoamine transporter, VMAT1 and VMAT2,
that are responsible for sequestering all of the differentVesicular monoamine transporters are known to trans-
monoamines into intracellular vesicles (Johnson, 1988;port monoamines from the cytoplasm into secretory
Erickson et al., 1992; Erickson and Eiden, 1993; Krejcivesicles. We have used homologous recombination to
et al., 1993; Peter et al., 1993; Surratt et al., 1993; Howellgenerate mutant mice lacking the vesicular mono-
et al., 1994; Liu et al., 1994; Schuldiner et al., 1995; Liuamine transporter 2 (VMAT2), the predominant form
and Edwards, 1997). VMAT1 is expressed primarily inexpressed in the brain. Newborn homozygotes die
endocrine and paracrine cells of peripheral organs,within a few days after birth, manifesting severely im-
whereas VMAT2 is expressed primarily in the nervouspaired monoamine storage and vesicular release. In
system and histaminergic cells in the gastrointestinalheterozygous adult mice, extracellular striatal dopa-
(GI) tract (Mahata et al., 1993; Gonzales et al., 1994;mine levels, as well as K1- and amphetamine-evoked
Peter et al., 1995; Dimaline and Struthers, 1996; Erickson
dopaminerelease, arediminished.The observed changes
et al., 1996; Nirenberg et al., 1997). Except in the adrenal
in presynaptic homeostasis are accompanied by apro-
chromaffin cells, VMAT1 and VMAT2 expression is al-
nounced supersensitivity of the mice to the locomotor
most mutually exclusive. The apparent lack of selectivity
effects of the dopamine agonistapomorphine, thepsy- for monoamines is compensated for by cell-specific
chostimulants cocaine and amphetamine, and etha- gene expression of the synthetic enzymes and the plasma
nol. Importantly, VMAT2 heterozygous mice do not membrane transporters. The vesicular monoamine trans-
develop further sensitization to repeated cocaine ad- porters derive the energy for transport from the vesicular
ministration. These observations stress the impor- proton gradient (Schuldiner et al., 1995). The proposed
tance of VMAT2 in the maintenance of presynaptic functions for the vesicular monoamine transporters are
function and suggest that these mice may provide (1) monoamine storage, (2) protection of monoamines
an animal model for delineating the mechanisms of from cytoplasmic oxidation, and (3) the regulation of
vesicular release, monoamine function, and postsyn- stimulated quantal release of monoamines (Amara,
aptic sensitization associated with drug abuse. 1995; Cooper et al., 1996).
Two pharmacological agents in particular have pro-
Introduction vided much insight into vesicular monoamine trans-
porter functions. Clinical use of the alkaloid reserpine,
Monoamines are important biomolecules that exert which binds to the vesicular transporters irreversibly
widespread physiological influences. In the CNS, mono- and dissipates monoamine stores, has highlighted the
amines serve as major neurotransmitters/neuromodula- important role of monoamines in CNS function and given
tors for the control of affective, cognitive, neuroendo- rise to the ªmonoamine hypothesisº of depression and
crine, and voluntary motor functions (Carlsson, 1987; other affective disorders (Schildkraut, 1965; Carlsson,
Cooper et al., 1996). Serotonin-, norepinephrine-, and 1987; Long and Kathol, 1993; Maes and Meltzer, 1994).
dopamine-synthesizing neurons have global projections The elegant genetic transfer of resistance to MPP1 tox-
throughout the brain and are widely viewed as essential icity to sensitive cells, which has led to the cloning of
components of the system that controls activation states the first cDNA for the vesicular monoamine transporters
of the organism. In the periphery, norepinephrine, hista- (Liu et al., 1992), has emphasized the protective role
mine, and serotonin are intimately involved in the reg- played by vesicular transport against oxidative stress
ulation of various autonomic, endocrine, and immune and neuronal toxins.Despite these advances, littledirect
functions (Daugherty et al., 1991). evidence exists as to the contribution of these pro-
cesses to the control of tissue homeostasis and respon-
siveness.
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Neuron
1286
Figure 1. Maps of the Targeting Vector and
the Mock Construct
The mouse genomic fragment clone 11 was
isolated from a Stratagene 129 SvJ library by
standard colony hybridization using a PCR
probe from the 59 end of rat cDNA. The re-
striction site abbreviations are: H, HindIII; N,
NotI; Sc, SacI; Sn, SnaI; X, XbaI; and Xh, XhoI.
The region between HindIII and SnaI on clone
11 containing the coding sequence for trans-
membrane domains 3 and 4 of VMAT2 was
deleted and replaced with PGK-neo. The 39
XbaI fragment of clone 11 was reserved as
an external probe for Southern analysis. To
facilitate PCR screening of embryonic stem
cell clones, a mock construct containing the
SnaI/XbaI fragment and part of the neomycin
cassette was made as a positive control.
pPNT and pGEM4Z are the two vectors used
to construct the knockout vector and mock
vector, respectively. Abbreviations: WT, wild-
type littermate; KO, knockout.
undetectable in newborn homozygous mice, growth of PCR screening of embryonic stem (ES) cell clones
(Figure 1). A 39 probe was selected for Southern blotis stunted, and most of them die within 1 week after
birth. Interestingly, adult heterozygous mice display pro- screening (Figure 1). Transfection using an ES cell line
(RW4) isogenic with the 129/SvJ substrain (Simpson etnounced hyperresponsiveness to the locomotor effects
of psychostimulants and ethanol despite only moderate al., 1997) yielded positive recombinant clones with a
targeting frequency of z20%. Of the six clones injectedchanges in the homeostasis of the dopamine system.
Thus, VMAT2-mediated intraneuronal monoamine trans- into C57BL/6 blastocysts, all gave rise to chimeric off-
spring, four of which succeeded in germline transmis-port is not only crucial for life-supporting functions of
the organism but is also an important regulator of post- sion. Two lines were bred independently to establish
the consistency of the phenotype and were found to besynaptic responsiveness to neurotransmitters.
identical in the initial analyses. Experimental animals
used in this study consisted of offspring derived from theResults
crossings of F1 (71%) and F2 (29%) mice. No observable
differences were seen between these offspring (BanburyGeneration of VMAT2 Knockout Mice
The mouse VMAT2 gene was isolated from a 129/SvJ Conference, 1997).
Figure 2A shows a Southern blot of SacI-digestedgenomic library with a PCR-generated probe comprised
of nucleotides 27±617 of the rat cDNA. Initial analyses DNA from the three genotypes. The wild-type littermate
lane (1/1) shows the expected 5.3 kb band and theof eight different clones showed that a particular clone
(13.7 kb) contained at its 39 end a region that spans from homozygote lane (2/2) shows the 6.9 kb mutant band.
The heterozygote lane (1/2) shows both the normal andthe carboxy-terminal portion of the putative transmem-
brane domain 2 (TMD2) to the amino-terminal portion mutant bands. Figure 2B displays RT±PCR results using
poly (A1) RNA from newborn whole brain. The primersof TMD8. A combination of sequencing and Southern
analyses revealed no coding sequence in the 10 kb re- were chosen to flank the PGK-neo cassette in order to
detect any potential readthrough transcripts. Figure 2Bgion at the 59 end of the clone. The identity of the mouse
VMAT2 gene was determined by sequence analysis and demonstrates that the homozygotes are completely
devoid of VMAT2 transcripts. Western blot analysis ofhomology comparison with the rat cDNA sequence.
While the coding sequences in the mouse VMAT2 gene whole-brain synaptic vesicles from newborn brains re-
vealed three VMAT2 immunoreactive bands in the wild-share over 90% homology with the rat VMAT2 cDNA,
these two genes are only z70% homologous with the type littermate, the most predominant band at 75 kDa
with fainter bands at 55 and 45 kDa (Figure 2C). ThisVMAT1 cDNA.
As shown in Figure 1, the sequences encoding TMD3 pattern of immunoreactivity has previously been de-
scribed for VMAT2 (Peter et al., 1995), with the 55 andand TMD4 of the VMAT2 gene were deleted and re-
placed with the PGK-neomycin (PGK-neo) cassette in 75 kDa being the native and glycosylated forms, respec-
tively, whereas the 45 kDa is of unknown origin. VMAT2the knockout construct. To eliminate the possibility that
the targeting construct might contain repetitive genomic immunoreactivity to the 75 and 55 kDa bands was mark-
edly reduced in the heterozygote and absent in the ho-sequences, which tend to reduce targeting frequency,
a reverse Southern blot experiment was performed us- mozygous VMAT2 knockout.
To further assess the loss of VMAT2, binding assaysing the targeting construct as template and fragmented
32P-labeled mouse genomic DNA as probe. The result were performed in brain vesicle preparations from new-
born brains using the high affinity compound 3H-dihy-confirmed that the total 8 kb genomic sequence used in
the targeting construct was free of repetitive elements. A drotetrabenazine. As expected, there was no binding in
the homozygote but a significant amount of binding inmock vector was constructed to facilitate quantitation
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the wild-type littermates (Figure 2D). The obtained KD
value, 0.1 nM, was within the range of published values
(Near 1986; Scherman, 1986; Meshgin-Azarian, 1988),
and the maximal capacity for VMAT2 binding (Bmax)
in wild-type littermate newborn mouse brain was 12
fmol/mg tissue.
Alterations in Brain Monoamine Homeostasis
and Neonatal Death of Homozygous
VMAT2 Mutant Mice
Offspring from the crossing of VMAT2 heterozygotes
yielded 24.9% homozygotes, 46.5% heterozygotes, and
28.6% wild-type littermates, reflecting a Mendelian ratio
of 1:2:1. The newborn pups homozygous for VMAT2
deletion appeared small and hypoactive and were more
prone to hypothermia. Their growth was severely stunted,
maintaining the body size of a newborn until death (Fig-
ure 3A). Of all the homozygotes born, the majority died
within 1±3 days of birth, although some survived as long
as 12 days (Figure 3B). Neonatal death in homozygous
mice did not appear to be due to gross anatomical ab-
normalities, since histopathological evaluation at the
light microscope level of whole-pup sagittal sections
revealed no remarkabledifference between the homozy-
gous and wild-type littermates except for the overall
decrease in body size (data not shown).
Figure 4A shows the whole-brain tissue content of
monoamines and metabolites from newborn pups mea-
sured by high performance liquid chromatography with
electrochemical detection (HPLC-EC). Although there
was only a slight decrease in monoamine levels in het-
erozygous newborns, the monoamine levels in homozy-
gotes were drastically reduced. Metabolite levels in both
populations were not significantly altered (e.g., 3,4-dihy-
droxyphenylacetic acid [DOPAC] and homovanillic acid
[HVA]), except for the serotonin metabolite 5-hydroxyin-
doleacetic acid (5-HIAA) levels in homozygotes, which
were significantly increased as compared to wild-type
littermate levels.
To assess the activities of tyrosine hydroxylase (TH)
and tryptophan hydroxylase, the rate-limiting enzymes
of monoamine synthesis, the L-aromatic amino acid de-
carboxylase inhibitor 3-hydroxybenzylhydrazine (NSD-
1015; Carlsson et al., 1972) was used to measure the
accumulation of L-DOPA and 5-hydroxytryptophanFigure 2. Confirmation of VMAT2 Gene Deletion
(5-HTP) in newborn brains. Figure 4B shows that both(A) Southern blot analysis of mouse genomic DNA. The Southern
blot was prepared with 15 mg of genomic DNA per lane and probed L-DOPA and 5-HTP levels were approximately doubled
with a 1.4 kb 39 external genomic fragment, as indicated in Figure 1. in homozygotes after NSD-1015 treatment, whereas the
Abbreviations: 1/1, wild-type littermate; 1/2, heterozygote; 2/2, heterozygotes showed intermediate changes. Interest-
homozygote. ingly, Northern blot analysis of TH mRNA in ventral mid-
(B) RT±PCR analysis of mouse brain poly (A1) RNA. Poly (A1) RNA
brain revealed no statistically significant differences(0.5 mg) was used for eachreverse transcription assay. Equal volume
among the three genotypes (data not shown).of cDNA templates was used for each PCR assay. The PCR primers
used flank the neomycin cassette (see Figure 1), for the purpose
of detecting potential readthrough from the neomycin cDNA. The
heterozygote (1/2) has a reduced amount of transcripts as com- a-tubulin. No difference in the level of a-tubulin immunoreactivity
pared to the wild-type littermate (1/1), while the homozygote (2/2) was observed between wild-type littermate and heterozygous
is devoid of transcription of VMAT2 (top). G3PDH (983 bp) was used VMAT2 knockout as determined by densitometric analysis using
as internal control (bottom). internal dilutional standards from wild-type littermate brain.
(C) Western blot analysis of whole brain synaptic vesicles. Samples (D) Tetrabenazine (TBZ) binding to brain vesicle preparations. New-
(25 mg) of vesicles were solubilized and separated by sodium dode- born whole brains were used to obtain vesicle preparations. Increas-
cyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE; 14%), ing concentrations of TBZ were used to inhibit binding of the tritiated
transferred to nitrocellulose, subjected to Western blot analysis with analog 3H-dihydrotetrabenazine (1 nM). Each point represents the
anti-VMAT2-Ct (top) or anti±a-tubulin (bottom) antibodies, and de- mean of three binding experiments performed in triplicate with sepa-
veloped with chemiluminescence. Molecular mass markers (kDa) rate brain vesicle preparations. The homozygote binding parallels
are shown on the left. To confirm equal loading and transfer of that of nonspecific binding. KD 5 0.1 nM and Bmax 5 12 fmol/mg
proteins, the blots were stripped and reprobed with an antibody to tissue.
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Figure 3. Phenotype and Survival Rate of Homozygous VMAT2
Figure 4. Analyses of Monoamine Content and Synthesis in New-Knockout Mice
born Mice(A) The homozygote phenotype. The homozygous mice are hypoac-
(A) HPLC analysis of total brain content of monoamines and metabo-tive and prone to hypothermia, and they exhibit severe growth retar-
lites. Newborn whole-brain homogenates were used for HPLC as-dation. The photograph shows two 10-day-old littermates. The ho-
sessment of the levels of monoamines and metabolites. Results aremozygote (smaller pup) weighs ,1/6 of that of the other pup.
presented as the mean 6 SEM for 8±11 brains. Dopamine (DA),(B) VMAT2 knockout mice survival. Two lines of VMAT2 knockout
norepinephrine (NE), and serotonin (5-HT) levels were negligible inmice have been bred continuously for comparison. Of all homozy-
homozygotes, whereas the metabolite levels remain approximatelygotes born, most die within a few days after birth. The longest life
the same (DOPAC and HVA) or elevated (5-HIAA), suggesting anspan was 12 days.
increase in the rate of degradation (*p , 0.05 versus control; Stu-
dent's t test).
(B) L-DOPA and 5-HTP accumulation in the brain after NSD-1015.Electrical stimulation of striatal slices from 2- to 4-day-
Newborn mice were injected s.c. with L-aromatic aciddecarboxylaseold wild-type littermate pups caused readily measurable
inhibitor 3-hydroxybenzylhydrazine (NSD-1015) at a dose of 100peak overflow of dopamine (0.5±1.0 mM) in response
mg/kg. Ninety minutes later, whole-brain homogenates were pre-
to local electrical stimulation as measured by cyclic pared and HPLC-EC was performed. Results are presented as the
voltammetry (Figure 5). However, no measurable dopa- mean 6 SEM of 5±8 animals per group. L-DOPA and 5-HTP levels
are doubled in the homozygotes after NSD-1015 treatment, indicat-mine overflow could be recorded in striatal slices from
ing an increase in the rate of synthesis.homozygous animals (Figure 5).
Deletion of One VMAT2 Allele in Adult Mice Impairs
Striatal Dopamine Storage and Release from the VMAT2 heterozygote adult striata (data not
shown). Adult heterozygotes displayed normal growthTo further characterize the effects of VMAT2 gene dis-
ruption on neurological function, subsequent studies and feeding behavior and did not show overt signs of
altered physiological function.were performed on adult heterozygous mice. Western
blot analysis of striata and substantia nigra confirm a To determine the effects of reduced VMAT2 gene ex-
pression on dopamine function, HPLC analyses of totalz50% reduction in the expression of VMAT2 in the
adult heterozygous mice as measured by densitometry. dopamine content in striatal tissue was performed. Tis-
sue dopamine content in adult heterozygote striatumReduced immunoreactivity was observed for each of
the 75 and 55 kDa VMAT2 immunoreactive bands (data was about 25% lower than in the wild-type littermates,
but the level of its metabolite DOPAC was significantlynot shown). This reduction in VMAT2 protein level is
reflected in a decrease (z50%) in the initial rate of elevated (36%; Figure 6A), suggesting an increase in
dopamine turnover as seen in the newborn mice (Figure3H-dopamine uptake (#1 min) in vesicular preparations
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of postsynaptic D1/D2 dopamine receptor activation by
this dose of apomorphine (Wilcox et al., 1980).
Increased sensitivity of the postsynaptic sites to the
direct dopamine agonist apomorphine suggested there
could be similar hyperresponsiveness to endogenous
dopamine released by the indirect agonists cocaine and
amphetamine. Administration of cocaine (20 mg/kg),
which elevates extracellular dopamine by inhibiting the
plasma membrane dopamine transporter (Amara, 1995),
resulted in significantly stronger behavioral effects than
in wild-type mice as indicated by the increased locomo-
tion of heterozygous animals (Figure 7B). Pretreatment
with either D1 (SCH23390, 0.1 mg/kg i.p., 30 min before
cocaine) or D2 (raclopride, 2 mg/kg i.p., 30 min before
cocaine) receptor antagonist prevented hyperlocomo-
tion produced by cocaine in both genotypes, showing
Figure 5. Dopamine Efflux Measurement by Cyclic Voltammetry that this response is mediated by dopamine acting at D1
A 30 Hz, 90 pulse electrical stimulation was used to evoke dopamine and D2 dopamine receptors (data not shown). Similarly,
release from newborn striatal slices. Data points were collected
upon administration of 0.5 mg/kg amphetamine, hetero-every 100 ms. Insets are cyclic voltammograms. In the wild-type
zygotes showed significantly more locomotor activitylittermate (1/1) slices, dopamine is detected. There was no detect-
than wild-type littermates as measured by the horizontalable dopamine release from the homozygote (2/2) slices.
activity parameter (Figure 7C). It should be noted that
the increased behavioral response to amphetamine in
VMAT2 heterozygous mice was present despite the re-4). No significant alterations in striatal tissue contents
duced ability of the drug to stimulate DA release in theseof the other dopamine metabolite, HVA, as well as sero-
animals (Figure 6D). Thus, removal of one allele of thetonin and 5-HIAA, were observed.
VMAT2 gene, which produces only a modest decreaseTo determine if extracellular brain levels of dopamine
in dopamine release (z40%; Figure 6B), surprisingly re-were altered in these mice, quantitative in vivo microdi-
sults in a profound behavioral supersensitivity to directalysis (low perfusion rate technique [Smith et al., 1992])
and indirect dopamine agonists. While the molecularon freely moving animals was performed. It revealed a
basis for this supersensitivity is still unknown, prelimi-40% reduction in extracellular striatal dopamine in the
nary observations indicate no appreciable changes inheterozygous mice (Figure 6B). Intrastriatal infusion of
the mRNA levels for D1 and D2 receptors. Interestingly,high K1 (100 mM) via the microdialysis probe demon-
the supersensitivity of the locomotor response in VMAT2strated impaired depolarization-evoked dopamine re-
heterozygotes was also observed upon administrationlease in VMAT2 heterozygous mice (Figure 6C). Simi-
of ethanol (Figure 7D).larly, amphetamine-evoked striatal dopamine release in
To determine whether this behavioral sensitization re-freely-moving animals was also markedly reduced in the
sembles the sensitization observed upon chronic co-heterozygous mice (Figure 6D), confirming the promi-
caine exposure, wild-type littermate and heterozygousnent contribution of vesicular dopamine in the action of
mice were subjected to a chronic cocaine sensitization
amphetamine.
paradigm (Figure 8; Hiroi et al., 1997). Cocaine was in-
jected every 24 hr for 6 days. Two days after the last
injection, mice were challenged with the same dose ofAltered Presynaptic Dopamine Function Is
cocaine. Consistent with previous reports (Woolverton
Associated with Supersensitivity to Direct
and Johnson, 1992; Hiroi et al., 1997), this paradigm
and Indirect Dopamine Agonists results in significantly heightened locomotor response
As previously noted with reserpinized animals (Carlsson, to the challenge dose of cocaine (eighth day) in wild-
1987; Callaway et al., 1989; LaHoste and Marshall, 1994), type littermates. However, VMAT2 heterozygous mice
decreased synaptic dopamine can result in receptor su- showed no further increase in locomotion on day 8 be-
persensitivity. To test this possibility in the VMAT2 het- yond the already enhanced response to cocaine on day
erozygous mice, we monitored open-field locomotor ac- 1. These results clearly demonstrate that these mice are
tivity as a paradigm. Results showed a similar pattern already maximally sensitized to cocaine.
of habituation to a novel environment in both genotypes,
although heterozygotes took slightly longer to habituate Discussion
as compared to wild-type littermates (data not shown).
Direct challenge of postsynaptic receptors with a high The deletion of the VMAT2 gene reported in this study
dose of the D1/D2 dopamine receptor agonist apomor- reveals the critical role the vesicular transporter plays
phine revealed a marked increase in behavioral respon- in vesicular uptake, storage, and release of mono-
siveness in heterozygotes versus wild-type littermates. amines. The results also highlight the essential role of
At 2 mg/kg, the druginduced more potent and prolonged the transport process in the normal development of the
stereotypic responses in VMAT2 heterozygotes (climb- animal. The homozygous knockout mice die shortly after
ing, Figure 7A, and licking, data not shown). These be- birth. The heterozygous knockout mice appear to de-
velop normally, exhibiting only moderate reductions inhaviors are characteristic manifestations of high levels
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monoamine levels. However, they display drastically al-
tered responses to numerous pharmacological agents.
These results provide new and exciting insight into how
impairment of presynaptic function can lead to alter-
ations in postsynaptic responsiveness.
VMAT2-Mediated Transport Regulates
Presynaptic Homeostasis
The absence of monoamines in vesicular stores re-
sulting from the lack of VMAT2 causes drastic changes
in monoamine homeostasis, which are strongly remi-
niscent of the effects of reserpine (Brodie et al., 1955;
Carlsson, 1987). Instead of accumulating in vesicles,
monoamines apparently become subject to enhanced
degradation, as is reflected in the nondeclining levels
of metabolites (Figure 4A). Interestingly, depletion of
vesicular monoamine stores by reserpine and tetrabena-
zine (TBZ) also leads to an increase in the rate of synthe-
sis (German et al., 1981). The fact that VMAT2 knockout
mice exhibit the same properties (Figure 4B) shows that
the elevations in synthesis rate are a direct result of
the disruption of vesicular storage and release pro-
cesses. The drop in both extracellular and intracellular
monoamines could lead to disengagement of end-prod-
uct inhibition (Spector et al., 1967; Macon et al., 1971)
and disinhibition of presynaptic autoreceptor-mediated
mechanisms (Wolf and Roth, 1990), which are normally
thought to regulate the activity of TH. Thus, the ex-
tremely low levels of monoamines in thebrains of VMAT2
knockout mice, despite their significantly elevated syn-
thetic rates, strongly suggest that VMAT2-mediated ve-
sicular transport is a major determinant of monoamine
storage in the CNS. Moreover, cyclic voltammetry, the
only technique suitable to measure dopamine release
in situ in the brain of newborn pups, demonstrates that
loading of vesicles by VMAT2 is mandatory for impulse-
dependent dopamine release in the striatum.
Importance of VMAT2-Mediated Transport
of Monoamines for Postnatal Survival
Given the previous evidence derived from the deletion
of other genes involved in the synthesis of monoamines,
such as those for TH and dopamine b hydroxylase (Zhou
and Palmiter, 1995; Thomas et al., 1995; Zhou et al.,
1995), that catecholamines are absolutely required for
fetal development, it is surprising that VMAT2 knockout
mice with essentially negligible brain levels or release
of monoamines can actually survive through gestation.
An important distinction between these other knockout
lines and the VMAT2 line is that the synthetic machineryFigure 6. Impaired Striatal Dopaminergic Transmission in Adult
VMAT2 Heterozygous Mice
(A) Tissue levels of monoamines and their metabolites in thestriatum
of adult VMAT2 heterozygote (1/2) and wild-type littermate (1/1)
mice measured by HPLC-EC. Results are presented as means 6 microdialysis. Data are presented as a percentage of the average
SEM of six mice per group of both VMAT21/2 and VMAT21/1 mice value of dopamine measured in at least three samples collected
(*p , 0.05 versus wild-type littermates; Student's t test). before the drug administration. Data points are means 6 SEM (n 5
(B) Extracellular dopamine levels in the striatum of freely moving 8 for VMAT21/2 and 4 for VMAT21/1 mice).
mice measured using quantitative low perfusion rate microdialysis (D) Effect of amphetamine (10 mg/kg. i.p.) on the extracellular dopa-
approach (Smith et al., 1992). Means 6 SEM are shown (n 5 8 for mine level in the striatum of freely moving mice. Data are presented
VMAT21/2 and 5 for VMAT21/1 mice; *p , 0.05 versus wild-type as a percentage of the average value of dopamine measured in at
littermates, Student's t test). least three samples collected before the drug administration. Re-
(C) Effect of high K1 (100 mM) depolarization on the extracellular sults are presented as means 6 SEM (n 5 7 for VMAT21/2 and 6
dopamine level in the striatum of freely moving mice assessed by for VMAT21/1 mice).
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Figure 8. Locomotor Activity Responses in VMAT2 Wild-Type Lit-
termate and Heterozygous Mice Subjected to a Chronic Cocaine
Sensitization Paradigm
The mice were injected daily with cocaine (20 mg/kg i.p.) for 6 days,
and 48 hr after the last injection animals were challenged with the
same dose of the drug. Locomotor activity measurements were
performed on days 1 and 8. The animals were habituated to the
locomotor activity monitor for 1 hr before the drug administration.
The activating effect of cocaine on locomotion is presented for the
first 15 min after administration, where concomitant stereotyped
behaviors characteristic for this dose of cocaine (Hiroi et al., 1997)
were negligible. Analysis of accumulated distances traveled by the
mice over 30 min, 1 hr, and 2 hr also revealed a lack of further
sensitization in VMAT2 heterozygous (1/2) mice (data not shown).
Data are presented as means 6 SEM (**p , 0.01; ***p , 0.001 versus
wild-type littermates for the first day group; Student's t test).
for monoamines remains in place in the VMAT2 knock-
out mice. The fact that VMAT1 is expressed in the pe-
ripheral organs such as the adrenal medulla (Makata et
al., 1993; Peter et al., 1995; Erickson et al., 1996) could
be an important contributing factor. It is also possible
that the vesicular compartmentalization of monoamines
is not absolutely required during fetal development and
ongoing synthesis suffices to carry fetuses to birth.
However, early during postnatal life when the various
CNS pathways become more precisely defined (Singer
et al., 1994; Lohof et al., 1996), enhanced monoamine
synthesis, as was observed in the newborn pups, is no
longer adequate and the adverse effects caused by the
lack of vesicular release become manifest. Without
vesicular monoamines, the pups fail to feed properly
and become increasingly akinetic. Although the severe
hypoactivity of the VMAT2 homozygotes and the re-
duced ability to suckle may be the cause of the neonatal
death, several other confounding problems may exist.Figure 7. Effects of Apomorphine, Cocaine, Amphetamine, and Eth-
Most hypothalamic and pituitary hormones are underanol on the Locomotor Activity of VMAT2 Heterozygous and Wild-
Type Littermates some degree of monoaminergic regulation (MuÈ ller, 1995);
thus, the hypothalamic±pituitary axis is likely to be(A) Time course of climbing behavior, measured as the time spent
by the animal in the vertical position per each 5 min interval for severely perturbed. In addition, histamine, a potent reg-
VMAT2 heterozygous (1/2) and wild-type littermates (1/1) after ulator of GI tract function, is present both in enteric
apomorphine (2 mg/kg s.c.) treatment. Datapoints indicate means 6 neurons and oxyntic cells of the stomach (Gonzales et
SEM.
al., 1994; Peter et al., 1995; Weihe et al., 1995; Erickson(B±D) Time course of horizontal locomotor response of VMAT21/2
et al., 1996). Since VMAT2 is the primary transporter inand VMAT21/1 mice in response to cocaine ([B]; 20 mg/kg i.p.), to
GI tract histaminergic vesicles (Merickel and Edwards,amphetamine ([C]; 0.5 mg/kg i.p.), and to ethanol ([D] 2 g/kg i.p.).
Data are presented as means 6 SEM. 1995; Dimaline and Struthers, 1996), its absence could
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lead to severe digestive dysfunction. Although the pre- is primarily responsible for these effects of ethanol
(Samson and Harris, 1992), it is possible that mecha-cise mechanisms responsible for neonatal death of
nisms similar to those involved in sensitization to otherVMAT2 homozygous pups remain to be clarified, these
drugs could be responsible for this increased sensitivityobservations highlight the critical importance of VMAT2-
(Geoge and Ritz, 1991).mediated vesicular transport and storage of mono-
It has long been appreciated that behavioral super-amines in life-supporting functions essential for postna-
sensitivity can be produced not only by low synaptictal growth and development.
agonist concentrations (e.g., by reserpine, denervation,
lesions) but also by chronic intermittent psychostimu-
lant administration. Postsynaptic sensitization resultingPresynaptic Storage and Release of Monoamines
from repeated administration of psychostimulants isas Important Determinants of Postsynaptic
believed to be a model of the initial stages of psycho-Receptor Responsiveness
stimulant addiction (Woolverton and Johnson, 1992;Even though the homozygous mice were of limited use
Robinson and Berridge, 1993; Nestler and Aghajanian,to characterize the adaptive changes that result from
1997). The finding that VMAT2 heterozygous mice, whichthe absence of VMAT2, the heterozygous adult mice
are reminiscent of reserpine-treated animals, are al-revealed interesting and unexpected insight into the role
ready maximally sensitized to cocaine clearly demon-of VMAT2 in monoamine homeostasis and responsive-
strates that biochemical mechanisms underlying theness. Reducing the number of functional transporters
behavioral sensitization to both ªlowº and ªhighº ago-by z50% slightly decreased (z25%) the tissue content
nist-induced supersensitivity may be common. More-of dopamine and resulted in a more appreciable decrease
over, these findings point to the potential use of these(z40%) in the basal extracellular levels of dopamine as
mice as a non-drug-induced animal model to elucidatemeasured by microdialysis. Thus, the expression level
the mechanisms of sensitization related to drug abuse.of VMAT2 in a monoaminergic cell calibrates the capac-
The molecular events responsible for postsynapticity of that cell to store the appropriate monoamine. This
supersensitivity have been proposed to reside withinis supported by a substantial reduction in K1- or am-
components of the signal transduction or transcriptionphetamine-evoked release of dopamine (Figures 6C and
mechanisms (Self and Nestler, 1995; Roberts et al.,6D). Thus, either the size of the releasable pools or the
1997). Cellular components that are normally modifiedamount of neurotransmitter in each vesicle might be
by exposure to psychostimulants, such as postsynapticunder the control of VMAT2.
receptors, G protein subtypes, kinases, effector pro-Examination of the locomotor behaviors of heterozy-
teins, metabolic enzymes, and so on, all represent validgous mice in response to the direct dopaminergic ago-
candidates to explain the phenotype of VMAT2 hetero-nist apomorphine or the psychostimulants cocaine and
zygous mice (Nestler and Aghajanian, 1997). These find-amphetamine revealed a link between VMAT2 and drug
ings also raise the interesting possibility that VMAT2
responsiveness. Despite the relatively modest decrease
gene mutations in humans may predispose the individ-
(z40%) in the levels of extracellular dopamine in hetero-
ual to drug-seeking behavior or perhaps increase the
zygous mice, a pattern of postsynaptic sensitization or
propensity to develop neurological disorders such as
hyperresponsiveness is established that is similar to the Tourette's syndrome (Singer, 1994) or schizophrenia
sensitization resulting from repeated administration of (Meltzer, 1987).
cocaine in rodents (Woolverton and Johnson, 1992) or
the hypersensitivity observed after long-term treatment Conclusions
with dopamine receptor antagonists (Seeman, 1988). To summarize, we have created a mouse line that is
The enhanced response to high doses of the direct do- devoid of VMAT2 gene expression. This lack of VMAT2
pamine agonist apomorphine suggests that this super- results in a drastic decrease in the levels of dopamine,
sensitivity involves postsynaptic D1/D2 dopamine re- norepinephrine, and serotonin, despite a near doubling
ceptor sensitization mechanisms (Wilcox et al., 1980). in the rates of synthesis in the brain. More importantly,
Cocaine and amphetamine, at doses that markedly ele- the fact that the absence of VMAT2 leads to a disap-
vate extracellular dopamine, also produced heightened pearance of stimulatedrelease provides in vivoevidence
locomotor response in VMAT2 heterozygous mice. This that stimulated vesicular release of monoamines is
enhanced response to cocaine is blocked by D1 and necessary for postnatal survival. In adult heterozygous
D2 dopamine receptor antagonists, further suggesting mice, there was a decrease in dopamine release, and
that postsynaptic dopamine receptor supersensitivity is this modest change induced marked postsynaptic sen-
responsible for this effect. It is well known, however, sitization to direct receptor agonists and psychostimu-
lants. These phenotypes stand as compelling evidencethat the other monoamines, particularly norepinephrine
for the indispensable roles vesicular monoamine trans-and serotonin, are also affected by these drugs (Robin-
port plays in maintaining proper functioning of the or-son and Berridge, 1993), and increased responsiveness
ganism. The VMAT2-deficient mouse line should serveof receptors for these monoamines in VMAT2 heterozy-
as an animal model to further explore not only the basicgous mice could also contribute to the increased loco-
mechanisms underlying monoamine functions but alsomotor response to psychostimulants. It should be noted
those involved in drug-induced behaviors.that supersensitivity of all of the monoamine receptors
can be detected in reserpinized animals (Boakes et al.,
Experimental Procedures1971; McNeill and Schalze, 1972; Renyi, 1986; LaHoste
and Marshall,1992). Interestingly, VMAT2 heterozygotes Mouse VMAT2 Gene Characterization
are also supersensitive to the activating effects of etha- The mouse VMAT2 gene was cloned from a Stratagene 129/SvJ
genomic library by standard colony hybridization method using anol. While it is not known which neurotransmitter system
VMAT2 Knockout Mice Are Supersensitive to Psychostimulants
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rat 59 cDNA PCR fragment as a probe (Figure 1). The primers used 3H-dihydrotetrabenazine was purchased from Amersham, and
TBZ was obtained from Fluka. For the binding assay, triplicate 50to generate the probe were GTGTGGCGCTATAACCGCGCAG and
CTGGAGAAGGCAAACATAACTG. A 13.7 kb genomic clone (clone ml reactions were used, each containing 30 ml vesicle membranes,
10 nM 3H-dihydrotetrabenazine, and increasing concentrations of11) was mapped by restriction analysis. The clone was digested
into three XbaI fragments (8 kb, 4.3 kb, and 1.4 kb), which were TBZ ranging from 1 nM to 1 mM, respectively. The data were ana-
lyzed with the Graphpad Prizm analysis program (Intuitive Softwarethen subcloned individually into pGEM4Z for further analysis. A com-
bination of double-stranded sequencing, PCR, and Southern blot for Science).
analysis was used to locate the exons and exon±intron boundaries.
The identity of VMAT2 was confirmed by alignment and homology Western Blot Analysis
analyses using the Geneworks program (IntelliGenetics). Samples of whole-brain synaptic vesicles (see Tetrabenazine Bind-
ing section) from 2-day-old wild-type littermate, heterozygous, and
homozygous VMAT2 knockout mice were solubilized in a bufferKnockout and Mock Vectors Construction
To make the knockout construct, a vector containing both PGK- containing 320 mM sucrose, 5 mM HEPES, 1 mg/ml leupeptin, 1 mg/
ml aprotinin, and 1 mg/ml pepstatin. Homogenates were centrifugedneo and PGK-tk cassettes (pPNT) was chosen (Tybulewicz et al.,
1991). The XbaI/HindIII 5.7 kb fragment at the 59 end of clone 11 at 2000 3 g for 5 min, andthe supernatant fraction was subsequently
centrifuged at 30,000 3 g for 30 min. The resulting pellet was resus-was subcloned into Bluescript SK1 and released with NotI/XhoI.
This fragment was then subcloned into pPNT. The 2.2 kb SnaI/XbaI pended in sample buffer (62.5 mM Tris-HCl, 20% glycerol, 2% SDS,
0.01% bromphenol blue, and 1 mM dithiothreitol) and subjected tofragment of clone 11 was blunt ended and subcloned into the blunt-
ended BamHI site of pPNT containing the above mentioned 5.7 kb sodium dodecyl sulfate±polyacrylamide gel electrophoresis (SDS-
PAGE; 14%). Proteins were transferred to nitrocellulose (Milliporefragment. The resulting construct pYW/VMAT2- is 15.2 kb in length
(Figure 1). A mock construct was prepared as a positive control for semi-dry transfer apparatus), and nonspecific sites were blocked
in 7.5% nonfat dry milk in TBS (135 mM NaCl, 2.5 KCl, 50 mM Tris,PCR screening of the ES clones after transfection with the external
1.4 kb XbaI fragment from the 39 end of clone 11 and the EcoRI/XbaI and 0.1% Tween-20 [pH 7.4]). Membranes were then incubated in
the presence of a polyclonal antibody to the human VMAT2 C termi-fragment of the knockout construct (Figure 1). Reverse Southern blot
analysis was performed using 32P-dCTP-labeled, randomly restric- nus (CTQNNIQSYPIGEDEESESD, J. Haycock, LSU Medical Center)
in TBS with 2.5% nonfat dry milk. VMAT2 antibody binding wastion-digested genomic DNA as probes and the knockout construct
as substrate DNA in the gel. detected using a goat anti-rabbit horseradish peroxidase secondary
antibody (Boehringer) and enhanced chemiluminescence (Pierce).
Blots were then stripped for 20 min at 808C (8 M urea, 100 mMES Cell Clone Selection, Genotyping,
2-mercaptoethanol, and 62.5 mM Tris [pH 6.8]) and reprobed withand Mouse Breeding
an antibody to a-tubulin (Sigma).The 107 129/SvJ/RW4 ES cells obtained from GenomeSystems were
electroporated with 25 mg of linearized pYW/VMAT2- DNA. The
transfected cells were grown in DMEM media with 400 mg/ml G418 HPLC Assessment of Brain Content of Monoamines
and Metabolitesfor 10 days. On day 2, 0.5 mg/ml gancyclovir was added. Surviving
clones were edge scraped for three primer PCR analysis, using (1) Newborn whole brains and striata of adult mice were homogenized
in 0.1M HClO4 containing 100 ng/ml 3,4-dihydroxybenzylaminea neomycin-coding sequence primer, TCGCAGCGCATCGCCTTCT
ATCG; (2) a VMAT2 genomic sequence primer external to the knock- (DHBA) as an internal standard. Homogenates were centrifuged for
10 min at 10,000 3 g. Supernatants were filtered through 0.22 mmout construct, CAAGAAGCAGGAAGGGCCTAGG; and (3) a VMAT2
genomic sequence primer within the deleted region, AGAGCGTGGG filter and analyzed for levels of dopamine, serotonin, DOPAC, HVA,
and 5-HIAA using HPLC-EC. Monoamines and metabolites wereCACTAACTGG.
Positive colonies were expanded and the genotypes were con- separated on a microbore reverse-phase column (C-18, 5 mm, 1 3
150 mm, Unijet, BAS) with a mobile phase consisting of 0.03 Mfirmed by Southern blot analysis with 10±20 mg of high salt purified
DNA using a 1.4 kb probe external to the 39 end of the knockout citrate-phosphate buffer with 2.1 mM octyl sodium sulfate, 0.1 mM
EDTA, 10 mM NaCl, and 17% methanol (pH 3.6) at a flow rate ofconstruct. Six undifferentiated clones were individually microin-
jected into C57BL/6 blastocysts and transferred into pseudopreg- 90 ml/min and detected by a 3 mm glass carbon electrode (Unijet,
BAS) set at 0.8 V. The volume of injection was 5 ml. For measure-nant mice. Two chimeric males showing germline transmission were
used to generate mice for experimental analyses. The breeding ments of norepinephrine as well as dopamine levels in the brains
of VMAT2 homozygous pups, catecholamines were concentratedcolony consisted of F1 (71%) and F2 (29%) mice, andthe experimen-
tal animals used were predominantly F2 mice. Mouse genotyping by adsorption to acid-washed aluminum oxide as described by Lin
et al. (1984). Determinations were performed using the same columnwas performed using the same PCR primers and Southern probe
mentioned above. and apparatus with a mobile phase consisting of 50 mM monobasic
sodium phosphate, 0.2 mM octyl sodium sulfate, 0.1 mM EDTA, 10
mM NaCl, and 10% methanol (pH 2.6). The potential applied wasPoly (A1) RNA Isolation and RT±PCR
0.65 V.Poly (A1) RNA was prepared with Invitrogen's FastTrack mRNA
Isolation System using 1- to 3-day-old mouse whole brain. RNA
(0.5 mg) was used in each reverse transcription assay to generate Determination of Monoamine Synthesis Rates In Vivo
To measure rates of dopamine, norepinephrine, and serotonin syn-template DNA for PCR (Invitrogen cDNA cycle kit). To detect poten-
tial transcript readthrough past the neomycin cDNA, two PCR prim- thesis, newborn pups were injected s.c. with the L-aromatic acid
decarboxylase inhibitor 3-hydroxybenzylhydrazine (NSD-1015;ers were designed using the mouse genomicDNA coding sequences
that flank the neomycin cassette in the knockout VMAT2 gene. The 100 mg/kg i.p.); 90 min later, the concentration of L-DOPA and
5-hydroxytryptophan (5-HTP) in the whole brain was determined59 primer sequence is TCCAATTCCCATGTTTGCTGGATTC and the
39 primer sequence is GGTAGCCCATGATAGGCATC. G3PDH prim- using HPLC-EC (Carlsson et al., 1972) for simultaneous in vivo mea-
surement of THand tryptophan hydroxylase activities. The measure-ers (Clontech) were used for internal controls.
ments were performed using the same chromatographic conditions
and mobile phase as described above for determination of norepi-Tetrabenazine Binding to Brain Vesicle Preparations
nephrine.Newborn whole brains were homogenized with cold 0.32 M sucrose
solution and centrifuged at 3000 3 g. The supernatant was further
centrifuged at 30,000 3 g, and the synaptosome-containing pellet Fast Scan Cyclic Voltammetry
Carbon-fiber electrodes were prepared as described previouslywas lysed with a hypotonic shock by ice-cold water. After the isoto-
nicity was restored with salt replacements, vesicle membranes were (Kawagoe, 1993). The electrode potential was linearly scanned from
20.4 to 1.0 V and back to 20.4 V at 300 V/s every 100 ms. To convertpelleted at 100,000 3 g. The final pellet was dispersed with a low
speed Polytron (Brinkmann Instruments) in binding buffer (50 mM the magnitude of current at the oxidation potential for dopamine
(0.5±0.7 V) to concentration, each electrode was calibrated with aPO4, 50 mM KCl, 10 mM NaCl, 5 mM MgCl2, and 2 mM EGTA [pH
7.4]) and used for binding assays. known concentration of dopamine at the end of the experiment.
Neuron
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Current measured at the oxidation potential for dopamine is directly Banbury Conference on Genetic Background in Mice (1997). Mu-
tant mice and neuroscience: recommendations concerning geneticproportional to the dopamine concentration. Slices (700 mm thick)
were prepared as previously described and submerged in a re- background. Neuron 19, 755±759.
cording chamber and superfused with an artificial cerebrospinal Boakes, R.J., Bradley, P.B., and Candy, J.M. (1971). Supersensitivity
fluid (ACSF). A 30 Hz, 90 pulse (3 s) electrical stimulation was used of central noradrenaline receptors after reserpine. Br. J. Pharmacol.
to evoke dopamine release in slices. 43, 443P±444P.
Brodie, B.B., Pletscher, A., and Shore, P.A. (1955). Evidence that
In Vivo Microdialysis serotonin has a role in brain function. Science 122, 968±972.
Mice were anesthetized with chloral hydrate (400 mg/kg i.p.) and
Callaway, C.W., Kuczenski, R., and Segal, D.S. (1989). Reserpineplaced in a stereotaxic frame. Dialysis probes (membrane length, 2
enhances amphetamine stereotypes without increasing amphet-mm; outer diameter, 0.24 mm; Cuprophane, 6 kDa cutoff, CMA-11,
amine-induced changes in striatal dialysate dopamine. Brain Res.CMA/Microdialysis, Solna, Sweden) with CMA-11 guide cannulae
505, 83±90.were implanted into the right striatum. The stereotaxic coordinates
Carlsson, A. (1987). Monoamines of the central nervous system: afor implantation of microdialysis probes were (in mm): anterior±
historical perspective. In Psychopharmacology: the Third Genera-posterior, 0.0; dorsal±ventral, 24.4; and lateral, 2.5 relative to
tion of Progress, H.Y. Meltzer, ed. (New York: Raven Press), pp.bregma (Franklin and Paxinos, 1997). Placement of the probe was
39±48.verified by histological examination subsequent to the experiments.
Following surgery, animals were returned to their home cages Carlsson, A., Davis, J.N., Kehr, W., Lindqvist, M., and Atack, C.V.
with free access to food and water. Twenty-four hours after surgery, (1972). Simultaneous measurement of tyrosine and tryptophan hy-
the dialysis probe was connected to a syringe pump and perfused droxylase activities in brain in vivo using an inhibitor of the aromatic
at 1 ml/min with ACSF composed of (in mM): Na1, 150; K1, 3.0; Ca21, amino acid decarboxylase. Naunyn Schmeidebergs Arch. Pharma-
1.4; PO42, 31.0; and Cl2, 155 (ESA, Bedford, MA) with 0.25 mM col. 275, 153±168.
ascorbate (pH 7.3). After a 1 hr equilibration period, the perfusates
Cooper, J.R., Bloom, F.E., andRoth, R.H., eds. (1996). The Biochemi-
were collected every 20 min. At least four control samples were
cal Basis of Neuropharmacology. (New York: Oxford University
taken before amphetamine was administered i.p. or Ringer solution
Press), pp. 226±409 and 480±510.containing 100 mM K1 was infused through the microdialysis probe.
Daugherty, D.F., Lucey, M.R., and Yamada, T. (1991). Gastric secre-Under these conditions, the basal levels of dopamine in striatal
tion. In Textbook of Gastroenterology. T. Yamada, ed. (Philadelphia:dialysates were 78.5 6 18.8 fmol/20 ml (n 5 10) for VMAT2 wild-
J. B. Lippincott Company), pp. 233±264.type (1/1) littermates and 41.3 6 10.2 fmol/20 ml (n 5 15) for VMAT2
heterozygous (1/2) mice. To measure ªtrueº extracellular concen- Dimaline, R., and Struthers, J. (1996). Expression and regulation
tration of dopamine, low perfusion rate microdialysis was performed of a vesicular monoamine transporter in rat stomach: a putative
(Smith et al., 1992). Ringer solution was perfused at a flow rate of histamine transporter. J. Physiol. 490, 249±256.
50 nl/min for 6±7 hr and collected to a tube containing 2 ml of Erickson, J.D., and Eiden, L.E. (1993). Functional identification and
0.4 M HClO4 every 90 min. Perfusate samples were assayed for molecular cloning of a human brain vesicle monoamine transporter.
dopamine using HPLC-EC under the same chromatographic condi- J. Neurochem. 61, 2314±2317.
tions described above.
Erickson, J.D., Eiden, L.E., and Hoffman, B.J. (1992). Expression
cloning of a reserpine-sensitive vesicular monoamine transporter.
Behavioral Activity Assessment
Proc. Natl. Acad. Sci. 89, 10993±10997.All spontaneous open-field locomotion and rearing behaviors of
Erickson, J.D., SchaÈ fer, M.K.-H., Bonner, T.I., Eiden, L.E., and Weihe,wild-type littermate and heterozygous mice of both genders were
E. (1996). Distinct pharmacological properties and distribution inmeasured in an Omnitech digiscan activity monitor (42 cm2). Activity
neurons and endocrine cells of two isoforms of the human vesicularstudies were performed between 10 a.m. and 2 p.m. Locomotor
monoamine transporter. Proc. Natl. Acad. Sci. 93, 5166±5171.activity was measured at 5 min intervals for 3 hr, and cumulative
counts were taken for data analysis. To evaluate the effects of Franklin, K.B.J., and Paxinos, G. (1997). The Mouse Brain in Stereo-
apomorphine, cocaine, amphetamine, ethanol, or saline on locomo- taxic Coordinates (San Diego: Academic Press).
tor behavior, mice were habituated to locomotor activity monitor Geoge, F.R., and Ritz, M.C. (1991). Common mechanisms of rein-
cages for 1 hr, and then drugs were administered either i.p. (cocaine, forcement from alcohol and other drugs. Alcohol Alcohol Suppl. 1,
amphetamine, ethanol, and saline) or s.c. (apomorphine). In cocaine 427±431.
sensitization experiments, mice were tested for locomotor activity
German, D.C., McMillen, B.A., Sanhera, M.K., Saffer, S.I., and Shore,at days 1 and 8. The mice were habituated to activity monitor cages
P.A. (1981). Effects of severe depletion on dopamine neuronal im-for 1 hr, and then they were challenged by cocaine.
pulse flow and on tyrosine hydroxylase regulation. Brain Res. Bull.
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Note Added in Proof
During review of this paper, a report describing similar pheno-
typic changes for a VMAT2 knockout mouse line appeared. The
reference is:
Takahashi, N., Miner, L.L., Sora, I., Ujike, H., Revay, R.S., Kostic, V.,
Jackson-Lewis, V., Przedborski, S., and Uhl, G.R. (1997). VMAT2
knockmout mice: heterozygotes display reduced amphetamine-
conditioned reward, enhanced amphetamine locomotion, and en-
hanced MPTP toxicity. Proc. Natl. Acad. Sci. USA 94, 9938±9943.
